Circulating Autoantibodies to Erythropoietin Are Associated with Human Immunodeficiency Virus Type 1–Related Anemia

Nikolaos V. Sipsas, Styliani I. Kokori, John P. A. Ioannidis, Despina Kyriaki, Athanasios G. Tzioufas, T. Kordossis

The Journal of Infectious Diseases · 1999 · 53 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

In a cohort of 204 unselected consecutive human immunodeficiency virus type 1 (HIV-1)-infected patients, the association of circulating autoantibodies to endogenous erythropoietin (EPO) with HIV-1-related anemia was studied. Circulating autoantibodies to EPO were present in 48 (23.5%) of the 204 patients studied. Circulating autoantibodies were an independent predictor of anemia (odds ratio [OR]=5.0; 95% confidence interval [CI], 2.5-9.9), as strong as other known causes of anemia. The association of anti-EPO antibodies with anemia became stronger when the analysis was limited to the group of patients without any medical condition causing anemia (OR=10.4; 95% CI, 3.2-33.9). Moreover, the effect on hemoglobin levels remained significant even after adjusting for other anemia parameters. Anti-EPO autoantibodies were associated with higher EPO levels (r=.25, P=.012) and with a more prominent EPO response to anemia. Our findings suggest that autoimmunity, among other factors, may contribute to the pathogenesis of HIV-1-related anemia.

References

8